Systemic immune-inflammation mediates the association between Klotho protein and metabolic syndrome: findings from a large-scale population-based study
- PMID: 39501238
- PMCID: PMC11536849
- DOI: 10.1186/s12944-024-02339-y
Systemic immune-inflammation mediates the association between Klotho protein and metabolic syndrome: findings from a large-scale population-based study
Abstract
Background: This study utilized large-scale population data from the National Health and Nutrition Examination Survey (NHANES) to elucidate the relationship between the Klotho protein and metabolic syndrome along with its components. We further investigated the possible mediating effect of inflammation on these relationships. Our objective was to identify biomarkers for risk stratification and potential therapeutic targets for metabolic syndrome.
Methods: This study enrolled 13,119 participants aged 40-79 years, spanning five NHANES cycles from 2007 to 2016, with complete information on metabolic syndrome and the Klotho protein. The definition of metabolic syndrome followed the criteria of the National Cholesterol Education Program-Adult Treatment Panel III. Survey-weighted logistic regression and subgroup analysis were used to explore the associations between serum Klotho protein levels and metabolic syndrome, along with its components. Mediation analysis was performed to investigate the mediating effects of inflammation-related markers, including white blood cells, neutrophils, lymphocytes, monocytes, the neutrophil-to-lymphocyte ratio (NLR), the platelet-to-lymphocyte ratio (PLR), the systemic immune-inflammation index (SII) and the monocyte-to-HDL ratio (MHR), with the aim of elucidating how the Klotho protein influences the onset and progression of metabolic syndrome.
Results: The study participants had an average age of 56.06 years (95% CI: 55.76-56.37), with a Klotho protein concentration of 798.10 pg/ml (95% CI: 656.50-980.50) and a 43.77% prevalence of metabolic syndrome (n = 5742). In the crude model, Klotho was negatively correlated with metabolic syndrome and its components, including central obesity, hypertension, and hypertriglyceridemia. After adjusting for all confounding factors, Klotho was demonstrated to be negatively associated only with metabolic syndrome (OR: 0.82, 95% CI: 0.70-0.97), hypertension (OR: 0.83, 95% CI: 0.70-0.98), and hypertriglyceridemia (OR: 0.78, 95% CI: 0.67-0.91). Subgroup and interaction analyses revealed significant interactions between age, sex, race/ethnicity, body mass index, and Klotho. Additionally, mediation analysis demonstrated that leukocytes, neutrophils and monocytes accounted for 34.78%, 31.91% and 7.13%, respectively, of the associations between Klotho and metabolic syndrome.
Conclusion: The serum concentration of Klotho protein was negatively associated with metabolic syndrome, with the relationship being partly mediated by systemic immune inflammation. The findings of this research revealed that the Klotho protein may be a valuable biomarker for risk stratification and a potential therapeutic target for metabolic syndrome.
Keywords: Biomarkers; Inflammation; Klotho; Metabolic syndrome; National Health and Nutrition Examination Survey.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
L-shaped association of systemic immune-inflammation index (SII) with serum soluble α-Klotho in the prospective cohort study from the NHANES database.Sci Rep. 2024 Jun 8;14(1):13189. doi: 10.1038/s41598-024-64050-3. Sci Rep. 2024. PMID: 38851827 Free PMC article.
-
Systemic immune-inflammation index mediates the association between abdominal obesity and serum klotho levels.Sci Rep. 2025 Feb 4;15(1):4205. doi: 10.1038/s41598-025-88015-2. Sci Rep. 2025. PMID: 39905076 Free PMC article.
-
Systemic immunoinflammatory indexes in albuminuric adults are negatively associated with α-klotho: evidence from NHANES 2007-2016.Ren Fail. 2024 Dec;46(2):2385059. doi: 10.1080/0886022X.2024.2385059. Epub 2024 Aug 13. Ren Fail. 2024. PMID: 39135529 Free PMC article.
-
Effects of Klotho in epilepsy: An umbrella review of observational and mendelian randomization studies.Epilepsy Behav. 2025 Mar;164:110231. doi: 10.1016/j.yebeh.2024.110231. Epub 2025 Jan 16. Epilepsy Behav. 2025. PMID: 39823737
-
Klotho Protein: A Multifaceted Guardian of Healthy Aging and Its Therapeutic Potential.Int J Nanomedicine. 2025 Jun 9;20:7251-7270. doi: 10.2147/IJN.S514516. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40520057 Free PMC article. Review.
Cited by
-
The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and hepatic steatosis and liver fibrosis among US adults based on NHANES.Sci Rep. 2025 Feb 23;15(1):6527. doi: 10.1038/s41598-025-90773-y. Sci Rep. 2025. PMID: 39988726 Free PMC article.
-
Association between dietary index for gut microbiota and metabolic syndrome risk: a cross-sectional analysis of NHANES 2007-2018.Sci Rep. 2025 Apr 30;15(1):15153. doi: 10.1038/s41598-025-99396-9. Sci Rep. 2025. PMID: 40307409 Free PMC article.
References
-
- Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement[J]. Curr Opin Cardiol. 2006;21(1):1–6. 10.1097/01.hco.0000200416.65370.a0. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical